US tariffs on metals and pharma: Which Indian stocks are safe and which aren't: Sudip BandyopadhyayIndian equity markets face policy risks from US tariffs and West Asia conflict. These issues impact metals and pharmaceutical sectors. Expe...
06 Apr, 2026, 01.24 PM IST
Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...
02 Apr, 2026, 12.13 PM IST
Glenmark Pharma to sell 7.84% stake in Glenmark Life via OFSThe stake sale will be done through the stock exchanges via an offer for sale (OFS). The decision was made at a meeting held today, and the...
10 Jul, 2024, 04.14 PM IST
Glenmark settles drug pricing case with US Department of JusticeUS-based Glenmark Pharmaceuticals Inc, a subsidiary of the company, has entered into a three-year deferred prosecution agreement with DOJ i...
22 Aug, 2023, 12.56 PM IST
Glenmark drops 6% as Q2 net profit declinesThe stock has nearly trebled from its March lows of Rs 168, and is up 39 per cent year-to-date.
09 Nov, 2020, 01.20 PM IST
Glenmark's Ankleshwar plant gets EIR report from USFDA"The EIR is issued by the FDA only if it finds the facility to be deemed acceptable," the company said in a BSE filing.
15 Mar, 2017, 11.42 AM IST
Prefer Glenmark on strong molecule pipeline; Sun Pharma a value arbitrage opportunity: Prakash DiwanThere are certain smaller names as well, which would start bouncing back, believes Diwan. The analyst pointed out that Suven Life has falle...
09 May, 2015, 12.08 PM IST
Need to be cautious on Glenmark amid negative news flow: Miintdirect.com"It is clearly a bad news for Glenmark until we do not know what would be the material impact," Gorakssakar said.
24 Dec, 2013, 04.44 PM IST
- Glenmark Pharmaceuticals gains 7% on Q2 results; brokerages maintain buy
The company had posted a net profit of Rs 56.58 crore for the quarter ended September 30, 2011, Glenmark Pharmaceuticals said in a statemen...
31 Oct, 2012, 11.27 AM IST
- Glenmark files arbitration claim against Napo Pharmaceuticals
Glenmark has filed arbitration claims against Napo Pharmaceuticals for ending a contract to develop and market diarrhea drug.
14 Dec, 2011, 04.07 AM IST
- 290-300 a decent level to get into Glenmark.: Ashwani Gujral, Market Strategist
Generally if you buy Glenmark when there is a bad news, it tends to have periods of good news as well.
18 Jan, 2011, 04.00 PM IST
- Glenmark Pharma may see more downside: Deepak Mohoni
The market conditions, in the last week or two, have been quite adverse and that usually has an impact on Glenmark.
18 Jan, 2011, 12.03 PM IST
- Buy Glenmark Pharma: Ashwani Gujral
"Glenmark is something that you can buy because the pharma space continues to look okay."
17 Jan, 2011, 11.01 AM IST
- Glenmark looks good medium term : Sharyans Resources
Glenmark is something which could be looked at from a positive aspect across several weeks and months, both at the current level as well as...
08 Dec, 2010, 11.31 AM IST
- Glenmark Pharma: Miles to go before new drug makes a mark
Glenmark’s partners — US-based Napo Pharmaceuticals and Salix Pharmaceuticals — have announced completion of phase-III trials for the drug ...
09 Nov, 2010, 01.58 AM IST
- Stay out of Glenmark as a long term investor: Deepak Mohoni
Deepak Mohoni, Director, trendwatchindia.com in a chat with ET Now gives his perspective on Glenmark.
11 May, 2010, 04.12 PM IST
- Optimistic about Glenmark: Gaurang Shah, Geojit BNP Paribas Financial Services
Gaurang Shah, Asst VP, Geojit BNP Paribas Financial Services, in a chat with ET Now talks about Glenmark.
04 May, 2010, 12.20 PM IST